Pharmacy Benefit Management

From Drug Benefit News - Armed with data from a pair of studies, Prime Therapeutics LLC is approaching manufacturers to see if they’d be willing to enter into innovative new contracts with the PBM. Drilling down on data such as whether use of a drug follows its indication and how the conditions that drugs are treating break down can help with managing some high-cost specialty drugs in particular. Read more

From Drug Benefit News - Health Care Service Corp. (HCSC) is enlisting pharmacists at four supermarket chains in five states to help improve medication adherence rates in its Medicare Advantage, Part D and dual-eligible populations with diabetes, hypertension and high cholesterol. Read more

Pharmacy Benefit Management Blog

By Lauren Flynn Kelly - April 14, 2016
In the latest squabble between drugstores and PBMs, the National Community Pharmacists Association (NCPA) on April 1 issued a letter to CMS Deputy Director Cynthia Tudor asserting that Medicare Part D plans and PBMs are not complying with a federal requirement to use drug pricing standards that “...
By Angela Maas - March 30, 2016
As high drug prices continue to make headlines and draw congressional ire, hepatitis C drugs and “Mr. Wu-Tang” Martin Shkreli seem to be getting a reprieve as focus turns to the prostate cancer drug Xtandi. On March 28, 12 members of Congress sent a letter to HHS Sec. Sylvia Burwell and Francis...
By Lauren Flynn Kelly - March 4, 2016
Since the introduction of direct-acting antivirals that in clinical trials demonstrated higher sustained virologic response (SVR) rates in hepatitis C patients than ever before, we’ve seen figures on sales, treatment costs, adherence levels, etc. For example, Harvoni (ledipasvir and sofosbuvir) and...

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?